Dr. Shruti Gohil, associate medical director [and professor] for epidemiology and infection prevention at UC Irvine’s School of Medicine, on Thursday described remdesivir as a sometimes “lifesaving” drug for COVID-19 patients. While there may have been some conflicting studies about remdesivir and many other treatments in the early days of the pandemic, Gohil pointed to nearly two years of solid evidence that it can help reduce the length and severity of COVID-19 cases. The drug was given to Trump, among others, and Gohil describes it as a “mainstay” of treatment protocols.
California Assembly candidate, vaccine skeptic Benjamin Yu talks about how COVID-19 sent him to ICU
The Orange County Register, Jan. 14, 2022
January 14, 2022